期刊文献+

独活寄生汤加减对类风湿性关节炎临床疗效及实验室指标的影响 被引量:15

Influence of Duhuo Jisheng Decoction on Rheumatoid Arthritis Patients and Its Effect on Laboratory Indicators
下载PDF
导出
摘要 目的:探讨独活寄生汤加减联合西药对类风湿性关节炎临床疗效分析及患者实验室指标的影响。方法:类风湿性关节炎患者76例根据随机分组法分为治疗组和对照组各38例。治疗组采用独活寄生汤加减联合西药治疗,对照组仅采用西药治疗。两组疗程均为3个月。对比分析两组治疗前后实验室指标水平变化、治疗后临床疗效及治疗期间不良反应发生情况。结果:治疗组治疗后RF、ESR及CRP水平变化显著低于对照组(P<0.05);两组治疗后TNF-α、IL-6水平变化较治疗前显著减少(P<0.05);治疗组治疗后TNF-α、IL-6水平变化显著低于对照组(P<0.05);治疗组总有效率(95.74%)显著高于对照组(71.05%)(P<0.05);治疗期间均未见明显不良反应。结论:独活寄生汤加减联合西药对类风湿性关节炎临床疗效明显,可明显改善患者实验室指标,从而改善患者症状、体征。 Objective: To investigate the influence of Duhuo Jisheng Decoction combined with western medicine for rheumatoid arthritis patients and its effect on laboratory parameters. Methods: 76 patients with rheumatoid arthritis were randomly divided into treatment group( n = 38) and control group( n = 38). The treatment group received Duhuo Jisheng Decoction combined with western medicine and western medicine treatment in control group. The treatment lasted three months. Comparative analysis on laboratory parameters changes,the therapeutic efficacy and adverse reactions during clinical treatment was carried out. Results: After treatment,RF,ESR and CRP levels were significantly lower than the control group's( P〈 0. 05). Two groups' TNF- α and IL- 6 levels after treatment were significantly reduced( P 〈0. 05).The treatment group's TNF- α and IL- 6 levels after treatment were significantly lower than the control group's( P〈 0. 05). The treatment group's total effective rate( 95. 74%) was significantly higher than that of the control group( 71. 05%)( P 〈0. 05). There was no adverse reaction during the treatment period. Conclusion: Duhuo Jisheng Decoction combined with Western medicine has clinically significant effect on rheumatoid arthritis and can significantly improve patients' laboratory tests to improve patient symptoms and signs.
出处 《中华中医药学刊》 CAS 北大核心 2015年第11期2798-2800,共3页 Chinese Archives of Traditional Chinese Medicine
关键词 独活寄生汤加减 西药 类风湿性关节炎 疗效 实验室指标 Duhuo Jisheng Decoction Western medicine rheumatoid arthritis effect laboratory parameters
  • 相关文献

参考文献14

  • 1赵金霞,苏茵,刘湘源,叶华,李茹,邹庆华,方勇飞,刘花香,李兴福,郭嘉隆,毕黎琦,顾菲,孙凌云,梅轶芳,张志毅,陈丽娜,朱平,李光韬,张卓莉,冷晓梅,赵岩,姜莉,邹和建,赵毅,刘毅,李蕾,王洪源,栗占国.早期类风湿关节炎分类标准及其诊断意义的探讨[J].中华风湿病学杂志,2012,16(10):651-656. 被引量:48
  • 2Jung YS, Park W, Na K, et al. Temperature - modulated nonco- valent interaction controllable complex for the long - term delivery of etanercept to treat rheumatoid arthritis E J ] Journal of Con- trolled Release: Official Journal of the Controlled Release Socie- ty,2013,171(2) :143 - 151.
  • 3邓娟,裴必伟,徐胜前,刘童,陈晨,徐建华.类风湿关节炎患者全身骨质疏松和局部骨侵蚀的关系研究[J].中华风湿病学杂志,2012,16(10):674-678. 被引量:22
  • 4Yanagawa N, Sakai F, Takemura T, et al. Pulmonary cryptococco- sis in rheumatoid arthritis (RA) patients: Comparison of imaging characteristics among RA, acquired immunodefieieney syndrome, and immunoeompetent patients [ J ]- European Journal of Radiolo- gy,2013,82( 11 ) :2035 -2042.
  • 5姚欣艳,李淑君,范伏元,章青梅.中西医结合治疗类风湿性关节炎临床观察[J].中华中医药学刊,2008,26(8):1815-1816. 被引量:7
  • 6Amett FC,Edworthy SM,Bloch DA,et al. The American Rheuma- tism Association 1987 revised criteria for the classification of rheu- matoid arthritis [J]. Arthritis Rheum,1988,31(3) :315 -324.
  • 7中药新药临床研究指导原则(试行)[S].北京:中国医药科技出版社,2002.98-99
  • 8Celikyay F,Yuksekkaya R,Inanir A,et al. Multidetector compu- ted tomography findings of the sternoclavicular joint in patients with rheumatoid arthritis [ J ]. Clinical imaging, 2013,37 ( 6 ) : 1104-1108.
  • 9Gabriel D, Lange N, Chobaz - Peclat V, et al. Thrombin - sen- sitive dual fluorescence imaging and therapeutic agent for detec- tion and treatment of synovial, inflammation in murine rheuma- toid arthritis[ J]. Journal of Controlled Release : Official Journal of the Controlled Release Society, 2012,163 ( 2 ) : 178 - 186.
  • 10张春华.甲氨蝶呤与来氟米特治疗类风湿性关节炎的临床疗效和安全性研究[J].重庆医学,2015,44(4):511-513. 被引量:119

二级参考文献46

共引文献295

同被引文献163

引证文献15

二级引证文献159

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部